Frontiers in Physiology (Feb 2024)

Mitochondrial quality control alterations and placenta-related disorders

  • Yamei Wu,
  • Yamei Wu,
  • Meng Li,
  • Meng Li,
  • Hao Ying,
  • Ying Gu,
  • Ying Gu,
  • Yunlong Zhu,
  • Yunlong Zhu,
  • Yanfang Gu,
  • Yanfang Gu,
  • Lu Huang,
  • Lu Huang

DOI
https://doi.org/10.3389/fphys.2024.1344951
Journal volume & issue
Vol. 15

Abstract

Read online

Mitochondria are ubiquitous in eukaryotic cells. Normal maintenance of function is the premise and basis for various physiological activities. Mitochondrial dysfunction is commonly observed in a wide range of pathological conditions, such as neurodegenerative, metabolic, cardiovascular, and various diseases related to foetal growth and development. The placenta is a highly energy-dependent organ that acts as an intermediary between the mother and foetus and functions to maintain foetal growth and development. Recent studies have demonstrated that mitochondrial dysfunction is associated with placental disorders. Defects in mitochondrial quality control mechanisms may lead to preeclampsia and foetal growth restriction. In this review, we address the quality control mechanisms of mitochondria and the relevant pathologies of mitochondrial dysfunction in placenta-related diseases, such as preeclampsia and foetal growth restriction. This review also investigates the relation between mitochondrial dysfunction and placental disorders.

Keywords